rs7206971
|
|
Low density lipoprotein cholesterol measurement
|
A |
0.800 |
GeneticVariation
|
GWASDB |
Discovery and refinement of loci associated with lipid levels.
|
24097068 |
2013 |
rs7206971
|
|
Serum total cholesterol measurement
|
G |
0.800 |
GeneticVariation
|
GWASCAT |
A large electronic-health-record-based genome-wide study of serum lipids.
|
29507422 |
2018 |
rs7206971
|
|
Low density lipoprotein cholesterol measurement
|
A |
0.800 |
GeneticVariation
|
GWASCAT |
Discovery and refinement of loci associated with lipid levels.
|
24097068 |
2013 |
rs7206971
|
|
Serum total cholesterol measurement
|
A |
0.800 |
GeneticVariation
|
GWASDB |
Discovery and refinement of loci associated with lipid levels.
|
24097068 |
2013 |
rs7206971
|
|
Low density lipoprotein cholesterol measurement
|
G |
0.800 |
GeneticVariation
|
GWASCAT |
A large electronic-health-record-based genome-wide study of serum lipids.
|
29507422 |
2018 |
rs7206971
|
|
Serum total cholesterol measurement
|
T |
0.800 |
GeneticVariation
|
GWASDB |
Biological, clinical and population relevance of 95 loci for blood lipids.
|
20686565 |
2010 |
rs7206971
|
|
Low density lipoprotein cholesterol measurement
|
A |
0.800 |
GeneticVariation
|
GWASCAT |
Multi-ancestry genome-wide gene-smoking interaction study of 387,272 individuals identifies new loci associated with serum lipids.
|
30926973 |
2019 |
rs7206971
|
|
Low density lipoprotein cholesterol measurement
|
T |
0.800 |
GeneticVariation
|
GWASDB |
Biological, clinical and population relevance of 95 loci for blood lipids.
|
20686565 |
2010 |
rs7206971
|
|
Serum total cholesterol measurement
|
A |
0.800 |
GeneticVariation
|
GWASCAT |
Biological, clinical and population relevance of 95 loci for blood lipids.
|
20686565 |
2010 |
rs7206971
|
|
Low density lipoprotein cholesterol measurement
|
A |
0.800 |
GeneticVariation
|
GWASCAT |
The impact of low-frequency and rare variants on lipid levels.
|
25961943 |
2015 |
rs7206971
|
|
Serum total cholesterol measurement
|
A |
0.800 |
GeneticVariation
|
GWASCAT |
Discovery and refinement of loci associated with lipid levels.
|
24097068 |
2013 |
rs7206971
|
|
Serum total cholesterol measurement
|
A |
0.800 |
GeneticVariation
|
GWASCAT |
The impact of low-frequency and rare variants on lipid levels.
|
25961943 |
2015 |
rs7206971
|
|
Low density lipoprotein cholesterol measurement
|
T |
0.800 |
GeneticVariation
|
GWASCAT |
Biological, clinical and population relevance of 95 loci for blood lipids.
|
20686565 |
2010 |
rs7206971
|
|
Serum LDL cholesterol measurement
|
A |
0.700 |
GeneticVariation
|
GWASDB |
Discovery and refinement of loci associated with lipid levels.
|
24097068 |
2013 |
rs7206971
|
|
Serum LDL cholesterol measurement
|
T |
0.700 |
GeneticVariation
|
GWASDB |
Biological, clinical and population relevance of 95 loci for blood lipids.
|
20686565 |
2010 |
rs62076505
|
|
mathematical ability
|
A |
0.700 |
GeneticVariation
|
GWASCAT |
Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals.
|
30038396 |
2018 |
rs1912483
|
|
Cardiovascular Diseases
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
rs113600793
|
|
Interleukin 12 Measurement
|
C |
0.700 |
GeneticVariation
|
GWASCAT |
Genome-wide Association Study Identifies 27 Loci Influencing Concentrations of Circulating Cytokines and Growth Factors.
|
27989323 |
2017 |
rs113600793
|
|
Interferon Gamma Measurement
|
C |
0.700 |
GeneticVariation
|
GWASCAT |
Genome-wide Association Study Identifies 27 Loci Influencing Concentrations of Circulating Cytokines and Growth Factors.
|
27989323 |
2017 |
rs113600793
|
|
Soluble Interleukin 6 Receptor Measurement
|
C |
0.700 |
GeneticVariation
|
GWASCAT |
Genome-wide Association Study Identifies 27 Loci Influencing Concentrations of Circulating Cytokines and Growth Factors.
|
27989323 |
2017 |
rs118004742
|
|
Prostate carcinoma
|
|
0.010 |
GeneticVariation
|
BEFREE |
The HDAC4 (2q37.2) variant rs73000144 (OR = 14.6, p = 0.018) and the EFCAB13 (17q21.3) variant rs118004742 (OR = 1.8, p = 0.048) were overrepresented in patients with familial PrCa.
|
25335771 |
2015 |
rs118004742
|
|
Malignant neoplasm of prostate
|
|
0.010 |
GeneticVariation
|
BEFREE |
The HDAC4 (2q37.2) variant rs73000144 (OR = 14.6, p = 0.018) and the EFCAB13 (17q21.3) variant rs118004742 (OR = 1.8, p = 0.048) were overrepresented in patients with familial PrCa.
|
25335771 |
2015 |